Stay updated on Branaplam Safety in Early Huntington's Disease Clinical Trial
Sign up to get notified when there's something new on the Branaplam Safety in Early Huntington's Disease Clinical Trial page.

Latest updates to the Branaplam Safety in Early Huntington's Disease Clinical Trial page
- Check3 days agoChange DetectedA minor metadata update shows revision v3.3.4 added and v3.3.3 removed; it does not alter study information, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check10 days agoChange DetectedAdded a new publication citation under Publications: Borowsky B, Ramos H, Caputo A, Hartmann A, Faller T, Peters T, Sui Y, Liu F, Meadowcroft M, David OJ, Laisney M, Kinhikar A, Marder KS, Tabrizi SJ, Landwehrmeyer GB, Leavitt BR. Oral splicing modulator branaplam in Huntington's disease: a phase 2 randomized controlled trial. Nat Med. 2026 Jan 5.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded a dedicated Locations section including Quebec and Catalonia. Updated to revision v3.3.3 and removed the prior Quebec Locations and Catalonia Locations sections.SummaryDifference0.3%

- Check55 days agoChange DetectedThe Publications section description was updated to indicate that publications are automatically filled in from PubMed, and the revision label was updated to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedThe government funding operating-status notice at the top of the page was removed, and the study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check76 days agoChange DetectedResults have been posted for NCT05111249 (Results First Posted 2024-11-04) and the record was updated on 2025-05-16. The study is terminated due to safety concerns related to potential peripheral neuropathy, with ongoing safety follow-up for participants.SummaryDifference0.4%

Stay in the know with updates to Branaplam Safety in Early Huntington's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Branaplam Safety in Early Huntington's Disease Clinical Trial page.